EU gives green light to another statin, Recordati's Livazo
This article was originally published in Scrip
Executive Summary
The EU has approved Recordati's Livazo (pitavastatin) for the reduction of elevated total cholesterol and LDL-cholesterol in adult patients with primary hypercholesterolaemia and combined dyslipidaemia when response to diet and other non-pharmacological measures are inadequate.